Transient ST-segment elevation in endovascular patent foramen ovale closure: a case report

Introduction. The complication rate of endovascular patent foramen ovale (PFO) closure is considered low. However, for most of complications, the rate has not been precisely determined. The most serious intraoperative complications include damage to the heart wall and vessels with bleeding, malpositioned occlude device, thromboembolism, and air embolism. Reports of severe and potentially fatal complications are rare, making their consideration and the determination of treatment strategies crucial.

Brief description. Patient K. aged 36 years had an ischemic stroke. Examination revealed a PFO with significant bypass grafting. Endovascular closure of the PFO was recommended to prevent recurrent ischemic events. During surgery, ST segment elevation was recorded in leads II and III. Selective coronary angiography revealed no contrast enhancement in the distal posterolateral and posterior descending arteries. Intracoronary nitroglycerin was administered, which restored flow in the artery. After the patient's condition stabilized, endovascular closure of the PFO was successfully completed, and an occluder was implanted.

Discussion. Possible causes of intraoperative ST segment elevation include gas embolism from air bubbles remaining in the delivery system after flushing, and mechanical irritation of the interatrial septum. Preventive measures include thorough flushing of the delivery system and selection of the occluder size based on heart anatomy.

1. Sposato LA, Albin CSW, Elkind MSV, et al. Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence. Stroke. 2024;55(1):236-47. doi:10.1161/STROKEAHA.123.040546.

2. Kulesh AA, Drobakha VE, Shestakov VV. Cryptogenic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2019;11(4):14- 21. (In Russ). doi.10.14412/2074-2711-2019-4-14-21.

3. Tereshenko AS, Merkulov EV, Arutyunyan GK. The patent foramen ovale. Harmless anomaly or a silent risk? M: Chazov National Medical Research Center of Cardiology, 2024. p. 128. (In Russ.) ISBN: 978-5-93856-767-2.

4. Kavinsky CJ, Szerlip M, Goldsweig AM, et al. SCAI Guidelines for the Management of Patent Foramen Ovale. J Soc Cardiovasc Angiogr Interv. 2022;1(4):100039. doi:10.1016/j.jscai.2022.100039.

5. Schulze V, Lin Y, Karathanos A, et al. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials. Clin Res Cardiol. 2018;107(9):745-55. doi:10.1007/s00392-018-1224-4.

6. Zhang QQ, Lu JJ, Yan MY, et al. The Efficacy of Percutaneous Patent Foramen Ovale Closure on Migraine: a Meta-Analysis of Randomized Controlled Trials and Observational Studies. Biomed Res Int. 2021;2021:6643266. doi:10.1155/2021/6643266.

7. Varotto L, Bregolin G, Paccanaro M, et al. Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse? Neurol Sci. 2021;42(1):101-9. doi:10.1007/s10072-020-04922-4.

8. De la Torre Hernandez JM, Fernandez-Valls M, Vazquez de Prada JA, et al. Transient ST Elevation: a Finding that May Be Frequent in Percutaneous Atrial Septal Defect Closure in Adults. Rev Esp Cardiol. 2002;55(6):686-8. Spanish. doi:10.1016/s0300-8932(02)76679-7.

9. Vijayvergiya R, Shrivastava S. Coronary air embolism during transcatheter closure of atrial septal defect. Indian Heart J. 2016;68(2):S79-80. doi:10.1016/j.ihj.2016.01.007.

10. Guragai N, Rampal U, Vasudev R, et al. Coronary vasospasm complicating atrial fibrillation ablation: a case report and review of the literature. J Community Hosp Intern Med Perspect. 2020;10(4):346-9. doi:10.1080/20009666.2020.1774252.